Swiss Federal Institute of Tech Spinal Implant Research Introduces Miracles

Nov 4, 2018 | CNS, Spinal Implant, Spine, Switzerland

Genentech/PTC Therapeutics Announce FDA Accepts NDA with Priority Review for Risdiplam for Spinal Muscular Atrophy

Research trials at the Swiss Federal Institute of Technology are now being called literal miracles for a select few who can now walk thanks to a revolutionary new spinal implant. Access the published study for more information. Also see a recent CNN article authored by James Griffiths and Wane Drash.

Lead Research/Investigator:

Emanuele Formento, Bertarelli Foundation Chair in Translational NeuroEngineering, Institute of Bioengineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland


Pin It on Pinterest